↓ Skip to main content

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Overview of attention for article published in Current Treatment Options in Oncology, June 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
54 Mendeley